Skip to main content

Harrow, Inc.

HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001360214

In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Harrow, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HROW: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders9390−3
Shares15.0M13.7M−1.34M (−8.9%)
Value$101.0M$125.7M+$24.7M (+24.4%)

New holders (20)

Institutions that held Harrow, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HROW in Q2 2021
InstitutionSharesValue% of portfolio
EAM Investors, LLC142,272$1.32M0.20%
Boothbay Fund Management, LLC100,635$935.0K0.04%
Ergoteles LLC69,900$649.0K0.01%
HRT Financial LP61,934$575.0K0.01%
Walleye Capital LLC52,230$485.0K0.02%
ExodusPoint Capital Management, LP48,912$454.0K0.01%
Jane Street Group, LLC41,118$382.0K0.00%
D. E. Shaw & Co., Inc.36,055$335.0K0.00%
Tibra Equities Europe Ltd32,400$301.0K0.09%
Citadel Advisors LLC23,713$221.0K0.00%
Cubist Systematic Strategies, LLC23,271$216.0K0.00%
Walleye Trading LLC16,469$153.0K0.00%
Virtu Financial LLC14,928$139.0K0.01%
Hancock Whitney Corp14,451$134.0K0.00%
LMR Partners LLP12,422$115.0K0.00%
Envestnet Asset Management Inc10,073$94.0K0.00%
Creative Financial Designs Inc1,545$34.0K0.01%
Barclays PLC2,462$23.0K0.00%
Signaturefd, LLC800$7.00K0.00%
Federated Hermes, Inc.70$1.00K0.00%

Sold out (23)

Institutions that held Harrow, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.